Dr. Thomas Vandemoortele, MD, MSc

Claim this profile

Centre hospitalier de l'Université de Montréal (CHUM)

Studies Lymphadenopathy
Studies Sarcoidosis
1 reported clinical trial
2 drugs studied

Affiliated Hospitals

Image of trial facility.
Centre Hospitalier De L'Université De Montréal (CHUM)

Clinical Trials Thomas Vandemoortele, MD, MSc is currently running

Image of trial facility.

Needle Size Impact on EBUS-TBNA

for Sarcoidosis and Lymphoma

The guided FNA by endobronchial ultrasound ( Endobronchial Ultrasound guided transbronchial Needle Aspiration or EBUS-TBNA) is a minimally invasive technique with an established role in the staging of lung cancer 1, and in the evaluation of intrathoracic lymph node metastases from extrathoracic primary cancer2 . There is also a role in cases of isolated hilar and mediastinal lymph nodes in which the differential diagnosis includes mostly sarcoidosis, lymphoma and tuberculosis. 3 Various studies have evaluated more recently the diagnostic yield of EBUS-TBNA specifically for sarcoidosis 4 and thoracic lymphoma 5-6. Although there is emerging data supporting the usefulness of EBUS-TBNA in the investigation of these two pathologies, the efficacy results vary according to the target populations and certain parameters. Moreover, although a large randomized study demonstrated e superiority of EBUS-TBNA over conventional bronchoscopic sampling methods \[ bronchoalveolar lavage (BAL) and trans-bronchial biopsies (TBB \] for the diagnosis of sarcoidosis , 7 the results suggest that there is still room for optimizing the performance of EBUS-TBNA \[b\] . In the field of lymphoma, obtaining large enough specimens for adequate subtyping also remains a concern. 8 In order to improve the performance of EBUS -TBNA , new needles have been developed with the aim to provide biopsies for histological evaluation rather than purely cytological. The ViziShot FLEX © (Olympus) 19 gauge needle (19 gauge or 19G) is a large needle, which can provide both tissue and needle aspiration , and has the advantage of being more flexible. For this study, the investigators want to compare the diagnostic yield of EBUS-TBNA using needle ViziShot FLEX 19G (1.11 mm) with that of the standard 22G needle ( NA-201SX; Olympus) , in the investigation of hilar or mediastinal lymphadenopathy suspected to be sarcoidosis or lymphoma.
Recruiting1 award N/A1 criteria

More about Thomas Vandemoortele, MD, MSc

Clinical Trial Related6 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Thomas Vandemoortele, MD, MSc has experience with
  • Vizishot 22G Needle
  • ViziShot FLEX 19G Needle

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Vandemoortele, MD, MSc specialize in?
Thomas Vandemoortele, MD, MSc focuses on Lymphadenopathy and Sarcoidosis. In particular, much of their work with Lymphadenopathy has involved treating patients, or patients who are undergoing treatment.
Is Thomas Vandemoortele, MD, MSc currently recruiting for clinical trials?
Yes, Thomas Vandemoortele, MD, MSc is currently recruiting for 1 clinical trial in Montreal Quebec. If you're interested in participating, you should apply.
Are there any treatments that Thomas Vandemoortele, MD, MSc has studied deeply?
Yes, Thomas Vandemoortele, MD, MSc has studied treatments such as Vizishot 22G needle, ViziShot FLEX 19G needle.
What is the best way to schedule an appointment with Thomas Vandemoortele, MD, MSc?
Apply for one of the trials that Thomas Vandemoortele, MD, MSc is conducting.
What is the office address of Thomas Vandemoortele, MD, MSc?
The office of Thomas Vandemoortele, MD, MSc is located at: Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec H2X 3E4 Canada. This is the address for their practice at the Centre hospitalier de l'Université de Montréal (CHUM).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security